Related Experiment Video
Updated: May 13, 2026
06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Scottish Enterprise - recognising capabilities in drug discovery and development
1Scottish Enterprise Edinburgh & Lothian, Apex House, 99 Haymarket Terrace, EH12 5HD, Edinburgh. ed.hutchinson@scotent.co.uk.
Expert Opinion on Drug Discovery
|March 19, 2013
Summary
Scotland
Area of Science:
- Life Sciences
- Personalised Medicine
- Pharmacogenomics
- Stem Cell Science
- Bioinformatics
- Systems Biology
Background:
- Scotland's life sciences sector has experienced significant growth.
- Increased investment highlights the strength of Scotland's research base.
- Focus on personalised medicine is a key driver of this expansion.
Purpose of the Study:
- To illustrate the growth of Scotland's life sciences sector.
- To highlight major initiatives in personalised medicine and related fields.
- To showcase advancements in pharmacogenomics, stem cell science, bioinformatics, and systems biology.
Main Methods:
- Review of recent scientific achievements and business development.
- Analysis of investment trends in Scotland's academic research.
- Examples of key initiatives in personalised medicine components.
Main Results:
- Rapid growth observed in scientific achievement and infrastructure.
- Increased internal and external investment signifies growing recognition.
- Advances in pharmacogenomics, stem cell science, bioinformatics, and systems biology are evident.
Conclusions:
- Scotland's life sciences sector is rapidly advancing, particularly in personalised medicine.
- Scientific progress in key disciplines will lead to improved personalised therapies.
- The sector's growth is supported by increased investment and research infrastructure.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...